Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term methylation. Found 13 abstracts

Mani S, Ghosh J, Coutifaris C, Sapienza C, Mainigi M. Epigenetic changes and assisted reproductive technologies. Epigenetics. 2020 Jan;15(1-2):12-25.   PMCID: PMC6961665
Li JG, Barrero C, Gupta S, Kruger WD, Merali S, Pratico D. Homocysteine modulates 5-lipoxygenase expression level via DNA methylation. Aging cell. 2017 Apr;16(2):273-80.   PMCID: PMC5334532
Overman MJ, Morris V, Moinova H, Manyam G, Ensor J, Lee MS, Eng C, Kee B, Fogelman D, Shroff RT, LaFramboise T, Mazard T, Feng T, Hamilton S, Broom B, Lutterbaugh J, Issa JP, Markowitz SD, Kopetz S. Phase I/II study of azacitidine and capecitabine/oxaliplatin (CAPOX) in refractory CIMP-high metastatic colorectal cancer: evaluation of circulating methylated vimentin. Oncotarget. 2016 Oct 11;7(41):67495-506.   PMCID: PMC5341892
Li H, Cai Q, Wu H, Vathipadiekal V, Dobbin ZC, Li TY, Hua X, Landen CN, Birrer MJ, Sanchez-Beato M, Zhang RG. SUZ12 Promotes Human Epithelial Ovarian Cancer by Suppressing Apoptosis via Silencing HRK. Molecular Cancer Research. 2012 Nov;10(11):1462-72.   PMCID: PMC 3501543
Hoffman AM, Cairns P. Epigenetics of kidney cancer and bladder cancer. Epigenomics. 2011 Feb;3(1):19-34.   PMCID: NIHMS362391
Makhov PB, Golovine KV, Kutikov A, Canter DJ, Rybko VA, Roshchin DA, Matveev VB, Uzzo RG, Kolenko VM. Reversal of epigenetic silencing of AP-2alpha results in increased zinc uptake in DU-145 and LNCaP prostate cancer cells. Carcinogenesis. 2011 Dec;32(12):1773-81.   PMCID: PMC3220607
Corney DC, Hwang CI, Matoso A, Vogt M, Flesken-Nikitin A, Godwin AK, Kamat AA, Sood AK, Ellenson LH, Hermeking H, Nikitin AY. Frequent Downregulation of miR-34 Family in Human Ovarian Cancers. Clinical Cancer Research. 2010 Feb;16(4):1119-28.   PMCID: PMCID: PMC2822884 [Available on 2011/2/15]
Howard JH, Frolov A, Tzeng CW, Stewart A, Midzak A, Majmundar A, Godwin AK, Heslin MJ, Bellacosa A, Arnoletti P. Epigenetic downregulation of the DNA repair gene MED1/MBD4 in colorectal and ovarian cancer. Cancer Biology & Therapy. 2009 Jan;8(1):94-100.   PMCID: PMC2683899
Xu J, Watts JA, Pope SD, Gadue P, Kamps M, Plath K, Zaret KS, Smale ST. Transcriptional competence and the active marking of tissue-specific enhancers by defined transcription factors in embryonic and induced pluripotent stem cells. Genes & development. 2009 Dec;23(24):2824-38.   PMCID: PMC 2800090
Burrows JF, Chanduloy S, McIlhatton MA, Nagar H, Yeates K, Donaghy P, Price J, Godwin AK, Johnston PG, Russell SH. Altered expression of the septin gene, SEPT9, in ovarian neoplasia. Journal of Pathology. 2003 Dec;201(4):581-8.
Kloeker S, Reed R, McConnell JL, Chang D, Tran K, Westphal RS, Law BK, Colbran RJ, Kamoun M, Campbell KS, Wadzinski BE. Parallel purification of three catalytic subunits of the protein serine/threonine phosphatase 2A family (PP2A(C), PP4(C), and PP6(C)) and analysis of the interaction of PP2A(C) with alpha4 protein. Protein Expression and Purification. 2003 Sep;31(1):19-33.
Graham DE, Bock CL, Schalk-Hihi C, Lu ZC, Markham GD. Identification of a highly diverged class of S- adenosylmethionine synthetases in the archaea. Journal of Biological Chemistry. 2000 Feb 11;275(6):4055-9.
Reczkowski RS, Markham GD. Slow binding inhibition of S-adenosylmethionine synthetase by imidophosphate analogues of an intermediate and product. Biochemistry. 1999 Jul 13;38(28):9063-8.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term methylation

methylation gene tumor-suppressor gene colorectal cancer metabolism expression drug therapy phosphatase inhibitors of rapamycin ezh2 azacitidine therapeutic use programming MED1 MBD4 Azacitidine methylome proliferation administration & dosage activator protein-2 promoter hypermethylation human somatic-cells germline mutations purification translational application Capecitabine molecular-cloning kinase-saccharomyces-cerevisiae-affinity- activation RCC rat methionine adenosyltransferases bladder cancer Tumor Biomarkers MICROSATELLITE cpg island rat-liver DNA methylation 5-lipoxygenase yeast Embryonic stem cells transcription factor ap-2 cell-proliferation in-vitro transcription ovarian carcinoma dna methylation phosphate REGION Vimentin ISLAND METHYLATOR PHENOTYPE gene-expression drug effects progression in-situ GLYCOSYLASE MBD4 HMLH1 surface epithelium 2 forms chromatin 1985 carty ks-archives of pathology & laboratory medicine-v109-p716 TRANSCRIPTS CARCINOMA cell-death homocysteine Male Organoplatinum Compounds growth induced pluripotent stem cells cpg-island methylation adverse effects endoderm atp analogs PROMOTER HYPERMETHYLATION renal cell Female specification KeyWords Plus: protein serine sites clear-cell Colorectal Neoplasms regulatory subunits chromatography-cell-growth-b-subunits-carboxyl apoptosis Neoplasm Drug Resistance MLL adenosyl-l-methionine CpG Islands tumor suppressor gene hzip1 colorectal-cancer DEFICIENCY carcinoma amyloid beta vimentin e-cadherin INSTABILITY Antineoplastic Combined Chemotherapy Protocols adenylyl imidodiphosphate renal-cell carcinoma Cimp terminal leucine residue serine threonine phosphatases-p70 s6 aberrant promoter epigenome protein MAMMALIAN SEPTINS p53 gene ovarian cancer HUMAN-DISEASE kinetics tumor-suppressor ap-2-alpha growth-factor-beta MED1 septin gene transcripts developmental regulators histone methyltransferase activity down-regulation DNA Methylation Adult genomic analyses Art 1986 carty ks-cancer research-v46-p4244 sequence PROTEIN hepatic CANCER CDCREL-1 INFANT Alzheimer's disease MUTATIONS microrna expression Middle Aged TUMORS blood Ivf enzyme-inhibitors mass-spectrometry alternative splicing ACUTE MYELOID-LEUKEMIA PP2A threonine phosphatase-PP4-PP6-alpha4-rapamycin-target prostate-cancer f1-atpase S-adenosylmethionine differentiation high-grade carcinomas Disease-Free Survival Aged cpg
Last updated on Saturday, June 06, 2020